Susceptibility to chromosome instability and occurrence of the regular form of Down syndrome in young couples

• Published in: Mutation research. Genetic toxicology and environmental mutagenesis 2022-09, Vol.881, p.503511-503511, Article 503511
• Main Authors: Vicic, Ana, Stipoljev, Feodora
• Format: Article
• Language: English
• Subjects: Micronucleus assay; Mitomycin C; Trisomy 21
• ISSN: 1383-5718; 1879-3592
• DOI: 10.1016/j.mrgentox.2022.503511

Although the risk of pregnancy with Down syndrome (DS) increases with age, conceptions with trisomy 21 can occur in mothers aged 35 or less. The micronucleus test on peripheral blood lymphocytes is a well-recognized method for studying chromosomal instability. The aim of this study was to evaluate the application of the micronucleus assay and fluorescence in situ hybridization (FISH) for estimation of chromosome instability and occurrence of trisomy 21 in young parents having pregnancy or a child with the regular form of Down syndrome. The study included 54 parents (27 couples) who had previous pregnancy with trisomy 21 at age 35 or less. The control group consisted of 30 couples with two healthy children and no previous spontaneous abortions. Parents with trisomy 21 pregnancy had significantly higher frequencies of micronuclei in binucleated cells. There was no statistically significant difference between the study and control groups in the frequencies of micronuclei in mononuclear cells, nuclear buds, or nucleoplasmic bridges. FISH analysis showed higher percentages of micronuclei containing whole chromosomes as well as statistically significant higher numbers of micronuclei containing chromosome 21 in the peripheral blood of DS parents. There was no statistically significant difference between the two groups in the responses of peripheral blood lymphocytes to treatment with the mutagen mitomycin C. Our results suggest that young parents with a history of the regular form of Down syndrome have a higher susceptibility to chromosome nondisjunction in peripheral blood lymphocytes. The micronucleus assay showed high specificity, but moderate sensitivity, for risk assessment of trisomy 21 pregnancy. •Young parents of Down syndrome have higher susceptibility to nondisjunction.•The micronucleus assay have high specificity for risk assessment of T21.•No significant difference was found in the response to mitomycin C treatment.